- Conditions
- Cancer of the Prostate, Genital Diseases, Genital Diseases, Male, +11 more
- Locations
-
- Clearview Cancer Institute (Crestwood) Huntsville, Alabama, United States
- Clearview Cancer Institute Huntsville, Alabama, United States
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Gilbert, Arizona, United States
Clinical trial condition
Hormone Sensitive Prostate Cancer
Explore clinical trials studying Hormone Sensitive Prostate Cancer. Study availability and eligibility vary by location and protocol.
13 public trials
5 recruiting studies
Hormone Sensitive Prostate Cancer trial results
NCT06392295
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- University of Miami Miami, Florida, United States
NCT05352178
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +18 more
- Locations
-
- University Hospitals Leuven Leuven, Belgium
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +14 more
- Locations
-
- Azienda Ospedaliera San Luigi Orbassano, Torino, Italy
- Istituto Oncologico Veneto Padova, Italy
- Santa Chiara Hospital Trento, Italy
NCT05983783
- Conditions
- Chemotherapy Effect, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Urology dpt, First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
Active, not recruiting
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
NCT04126070
- Conditions
- Hormone Sensitive Prostate Cancer, Metastasis Prostate Adenocarcinoma, Prostate Adenocarcinoma
- Locations
-
- University of California, San Diego La Jolla, California, United States
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- The Johns Hopkins University School of Medicine Baltimore, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Active, not recruiting
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837
- Conditions
- Cancer of the Prostate, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States
- Alaska Urological Institute dba Alaska Clinical Research Center Anchorage, Alaska, United States
Active, not recruiting
Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
NCT06463457
- Conditions
- Advanced Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, not recruiting
[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
NCT06229366
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
- Locations
-
- Juravinski Hamilton, Canada
- Jewish General Hospital Montreal, Canada
- McGill University Montreal, Canada
- Centre Hospitalier Universite de QUEBEC Québec, Canada
Active, not recruiting
PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
NCT06479187
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States